Type 2 diabetes trials in South Korea

In South Korea 64 Also abroad 1200

11 of 64 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Where
Seongnam-si
Age
19 years and over
People
10,000
Run by
Chong Kun Dang Pharmaceutical
See details and how to joinNCT06838286
No phaseTaking people
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Where
Seoul
Age
30 years to 65 years
People
1,000
Run by
Jae Yong Jeon, MD
See details and how to joinNCT07595718
No phaseNot yet taking people in South Korea
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
Where
Hwaseong-si
Age
19 years and over
People
100
Run by
Dongtan Sacred Heart Hospital
See details and how to joinNCT07770737
No phaseNot yet taking people in South Korea
CGM-Based Glycemic Analysis After ESI
Where
Seoul
Age
20 years to 60 years
People
36
Run by
Korea University Anam Hospital
See details and how to joinNCT07280780
No phaseEnrolling by invitation
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
Where
Seoul
Age
19 years and over
People
800,000
Run by
Novo Nordisk A/S
See details and how to joinNCT07673822
No phaseEnrolling by invitation
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Where
Jeonlabuk-do
Age
19 years and over
People
600
Run by
Novo Nordisk A/S
See details and how to joinNCT05689372
No phaseTaking people
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Where
Incheon
Age
19 years and over
People
9,000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05970237
No phaseTaking people
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Where
Seoul
Age
19 years and over
People
12,000
Run by
Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT06647888
No phaseTaking people
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Where
Seoul
Age
19 years and over
People
1,000
Run by
Kiyuk Chang
See details and how to joinNCT05770687
No phaseTaking people
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
Where
Andong, Seoul
Age
19 years and over
People
10,000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06649162
No phaseEnrolling by invitation
The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
Where
Yangcheon
Age
20 years to 80 years
People
716
Run by
Ewha Womans University Mokdong Hospital
See details and how to joinNCT05029115